HNGE vs HIMS vs LFMD Stock Comparison

Hinge Health, Hims & Hers Health and LifeMD Prices as of Nov 16, 2026 Peers: Industry group
1 more company in this comparison (ELV) Create a free account to keep reading and compare up to 10 companies.
HNGE Hinge Health, Inc.
$121.24 +22.2% 1M +196.0% 1Y
Market cap
$9.19B
P/E
55.1x
Revenue (TTM)
$800.82M
Div. yield
–
Telehealth Healthcare
6 wins
LFMD LifeMD, Inc.
$1.85 -20.9% 1M -60.0% 1Y
Market cap
$86.29M
P/E
–
Revenue (TTM)
$189.62M
Div. yield
–
Telehealth Healthcare

Head to Head

7 decided of 12

Hinge Health leads on 6 of the 12 questions below (Hinge Health 6, Hims & Hers Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHNGEHIMSLFMDLeader
Larger companyMarket capitalisation $9.19B $4.13B $86.29M HNGE
Cheaper on earningsLower P/E, profitable companies only 55.1x -21.7x -4.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 42.9x — — –
Faster revenue growthRevenue growth, trailing twelve months +49.9% +29.8% +5.3% HNGE
More profitableNet margin, trailing twelve months 20.8% -6.6% -10.8% HNGE
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +196.0% -49.8% -60.0% HNGE
Better 5-year returnAnnualised price return, 5 years — +18.0%/yr -17.3%/yr HIMS
Less volatileAnnualised volatility, 1 year 51.1% 91.2% 89.2% HNGE
Higher overall scoreMean of the five percentile scores vs peers 70/100 38/100 26/100 HNGE

Percentile Scorecard

HNGEHIMSLFMD

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHNGEHIMSLFMD
Valuation 27 #73 of 99 36 #64 of 99 16 #83 of 99
Growth 97 #4 of 89 24 #68 of 89 30 #63 of 89
Profitability 99 #2 of 92 33 #62 of 92 22 #72 of 92
Financial Health 45 #57 of 103 20 #83 of 103 10 #93 of 103
Shareholder Returns 84 #11 of 63 76 #16 of 63 55 #29 of 63
Overall 70 38 26
  • HNGE ranked among 103 companies in Healthcare Providers
  • HIMS ranked among 103 companies in Healthcare Providers
  • LFMD ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHNGEHIMSLFMDSPY
1 month +22.2%-33.9%-20.9% -3.0%
3 months +37.9%-35.2%-44.3% -4.2%
6 months +121.6%-16.7%-56.4% +0.2%
Year to date +161.0%-42.8%-45.7% +8.5%
1 year +196.0%-49.8%-60.0% +10.1%
3 years —+148.5%-74.3% +64.1%
3 years, per year —+35.5%-36.4% +18.0%
5 years —+128.6%-61.3% +58.1%
5 years, per year —+18.0%-17.3% +9.6%
10 years ——+48.0% +239.6%
10 years, per year ——+4.0% +13.0%

Risk

MeasureHNGEHIMSLFMDSPY
Volatility, 1Y 51.1%91.2%89.2% 13.8%
Downside volatility, 1Y 47.1%86.9%82.9% 14.2%
Beta vs S&P 500, 1Y 1.112.591.84 1.00
Return / volatility, 1Y 3.84-0.55-0.67 0.74
Max drawdown, 5Y -48.5%-78.9%-89.0% -25.4%
From 52-week high -1.6%-53.6%-64.9% -5.0%
52-week high $123.17$40.02$5.27 $779.14
52-week low $31.17$14.52$1.65 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHNGEHIMSLFMD
P/E now vs peer median 56.0xmedian 22.4x -24.2xmedian 22.4x -5.1xmedian 22.4x
P/S now vs peer median 11.7xmedian 1.3x 1.6xmedian 1.3x 0.6xmedian 1.3x
EV/EBITDA now vs peer median 40.0xmedian 14.2x -33.4xmedian 14.2x -2.7xmedian 14.2x
P/FCF now vs peer median 29.1xmedian 19.0x 145.7xmedian 19.0x -9.4xmedian 19.0x
P/B now vs peer median 31.3xmedian 2.6x 13.0xmedian 2.6x -182.3xmedian 2.6x
PEG now vs peer median —median 0.84 0.35median 0.84 -0.23median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHNGEHIMSLFMD
Revenue $800.82M $2.87B $189.62M
Gross profit $686.54M $1.83B $249.62M
Operating income $150.09M -$232.48M -$37.14M
Net income $168.31M -$190.81M -$483.28K
Free cash flow $322.00M $31.68M -$11.25M
R&D $134.62M $212.19M $7.29M
EPS (diluted) $1.93 $-0.82 $-0.43
Cash & equivalents $211.55M $605.60M $21.92M
Shares (diluted) 86.53M 233.82M 48.18M
Enterprise value $7.82B $1.25B -$59.62T

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHNGEHIMSLFMD
P/E 56.0x -24.2x -5.1x
P/FCF 29.1x 145.7x -9.4x
P/Operating cash flow 29.0x 25.6x -9.9x
P/S 11.7x 1.6x 0.6x
P/B 31.3x 13.0x -182.3x
P/Tangible book 40.6x -110.0x -141.6x
EV/EBITDA 40.0x -33.4x -2.7x
EV/EBIT 60.5x -16.8x -2.3x
EV/Revenue 11.3x 1.4x 0.4x
EV/FCF 28.2x 123.2x -7.4x
EV/Operating cash flow 28.1x 21.7x -7.8x
PEG (3Y EPS CAGR) – 0.35 -0.23

Growth

14 metrics
MetricHNGEHIMSLFMD
Revenue growth (1Y) 49.9% 29.8% 5.3%
Revenue CAGR (3Y) – 53.6% 11.8%
Gross profit growth (1Y) 63.4% 10.4% 66.3%
Gross profit CAGR (3Y) – 41.7% 28.3%
Operating income growth (1Y) 127.2% -302.1% -333.2%
Operating income CAGR (3Y) – -78.8% -17.8%
Net income growth (1Y) 131.6% -242.6% 94.6%
Net income CAGR (3Y) – -74.8% 73.6%
EPS growth (1Y) 135.4% -251.7% -43.2%
EPS CAGR (3Y) – -68.7% 22.8%
Operating cash flow growth (1Y) 121.4% -44.6% -184.8%
Operating cash flow CAGR (3Y) – 59.0% -125.2%
Free cash flow growth (1Y) 121.4% -76.3% -204.2%
Free cash flow CAGR (3Y) – -3.1% -151.8%

Profitability

14 metrics
MetricHNGEHIMSLFMD
Gross margin 85.7% 63.8% 131.6%
EBITDA margin 28.3% -4.1% -16.3%
Operating margin 18.7% -8.1% -19.6%
Pretax margin 20.8% -7.7% -19.5%
Net margin 20.8% -6.6% -10.8%
FCF margin 40.2% 1.1% -5.9%
Operating cash flow margin 40.3% 6.3% -5.6%
Return on equity 52.2% -65.9% 18.4%
Return on assets 19.7% -6.2% 0.0%
Return on invested capital – – –
Return on capital employed 49.0% -10.8% 0.0%
Asset turnover 0.9x 0.8x 0.0x
Cash conversion (OCF / net income) 1.9x -0.9x 22.2x
Stock comp / revenue 8.4% 6.2% 1.8%

Financial Health

11 metrics
MetricHNGEHIMSLFMD
Debt / assets – – –
Debt / equity – – –
Net debt / EBITDA – – –
Debt / FCF – – –
Liabilities / assets 65.7% 90.0% 100.9%
Equity / assets 34.3% 10.0% -0.9%
Interest coverage – – -41.1x
Current ratio 1.0x 0.9x 0.8x
Quick ratio 0.9x 0.8x 0.6x
Cash ratio 0.5x 0.5x 0.4x
Altman Z-score 9.84 1.29 -3.68

Shareholder Returns

7 metrics
MetricHNGEHIMSLFMD
Dividend yield – – –
Net buyback yield 2.2% 1.3% -0.1%
Shareholder yield 2.2% 1.3% -0.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHNGEHIMSLFMD
Forward P/E 42.9xFY2026 – –
EPS, next fiscal year $2.69FY2026 $-0.93FY2026 $-0.56FY2026
EPS growth, next FY +2.7%FY2026 -282.4%FY2026 -324.0%FY2026
EPS growth, the year after +20.8% – –
Revenue, next fiscal year $899.57MFY2026 $3.28BFY2026 $197.89MFY2026
Revenue growth, next FY +53.0%FY2026 +39.8%FY2026 +2.0%FY2026
Revenue growth, the year after +29.5% +25.4% +15.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHNGEHIMSLFMD
Held by institutions 92.1% 69.3% 45.2%
Institutions holding 279 510 117
Change in shares held, QoQ +2.5% +4.4% +21.3%
Institutions buying 198 325 71
Institutions selling 66 130 25
Buyers to sellers 3.00 2.50 2.84

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HNGEHIMSLFMD
HNGE 1.00 0.27 0.16
HIMS 0.27 1.00 0.45
LFMD 0.16 0.45 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HNGE, HIMS and LFMD?

Hinge Health (HNGE) is the largest by market capitalisation: Hinge Health (HNGE) $9.19B, Hims & Hers Health (HIMS) $4.13B, LifeMD (LFMD) $86.29M.

Which company is growing faster?

Hinge Health (HNGE) grew revenue fastest over the trailing twelve months: Hinge Health (HNGE) +49.9%, Hims & Hers Health (HIMS) +29.8%, LifeMD (LFMD) +5.3%.

Which company is more profitable?

Hinge Health (HNGE) has the highest net margin (Hinge Health (HNGE) 20.8%, Hims & Hers Health (HIMS) -6.6%, LifeMD (LFMD) -10.8%).

Which stock has performed better?

Over the past year Hinge Health (HNGE) returned the most: Hinge Health (HNGE) +196.0%, Hims & Hers Health (HIMS) -49.8%, LifeMD (LFMD) -60.0%. Over five years, Hims & Hers Health (HIMS) compounded fastest (Hims & Hers Health (HIMS) +18.0%/yr, LifeMD (LFMD) -17.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Hinge Health (HNGE) has been the steadiest (Hinge Health (HNGE) 51.1%, Hims & Hers Health (HIMS) 91.2%, LifeMD (LFMD) 89.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HNGE, HIMS and LFMD?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Hinge Health (HNGE) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.